Regarding CXCL13, a few studies found that higher CSF levels in CIS patients were associated with the risk of fulfilling McDonald criteria for RMS while one study demonstrated a high risk of conversion to CDMS in patients with optic neuritis [52–54]. The gene discussed is CXCL13; the disease is in situ carcinoma.